Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer
Kai Nan,1,* Lei Zhang,2,* Yujia Zou,3 Zilong Geng,3 Jing Huang,4 Yulong Peng,4 Su Yin,4 Ming Zhang5 1Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, 710054, People’s Republic of China; 2Department of Pharmacy, Shaanxi Provincial Hospital of C...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | ImmunoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/integrated-profiling-delineated-kif18a-as-a-significant-biomarker-asso-peer-reviewed-fulltext-article-ITT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850077808680763392 |
|---|---|
| author | Nan K Zhang L Zou Y Geng Z Huang J Peng Y Yin S Zhang M |
| author_facet | Nan K Zhang L Zou Y Geng Z Huang J Peng Y Yin S Zhang M |
| author_sort | Nan K |
| collection | DOAJ |
| description | Kai Nan,1,* Lei Zhang,2,* Yujia Zou,3 Zilong Geng,3 Jing Huang,4 Yulong Peng,4 Su Yin,4 Ming Zhang5 1Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, 710054, People’s Republic of China; 2Department of Pharmacy, Shaanxi Provincial Hospital of Chinese Medicine, Xi’an, Shaanxi, 710003, People’s Republic of China; 3Department of Orthopaedics, The second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710000, People’s Republic of China; 4Department of Rehabilitative Medicine, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, People’s Republic of China; 5Department of General Practice, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, 710054, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ming Zhang, Department of General Practice, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, 710054, People’s Republic of China, Email zhangminghonghui@yeah.netPurpose: Kinesin family member 18A (KIF18A) is a member of the kinesin-8 family of motor proteins, involved in the progression and metastasis of various tumors. However, its role in pancreatic adenocarcinoma (PAAD) remains unclear.Methods: To evaluate that role, RNA sequencing datasets, complemented by pertinent clinical metadata, were procured from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) repositories. The protein expression level of KIF18A in PAAD was derived from human protein atlas (HPA) database. The differences in KIF18A expression levels and prognostic related genes were identified through multivariate Cox regression and Lasso regression analysis to construct a prognostic risk model. The Tumor Mutation Burden (TMB), Microsatellite (MSI), immune landscape, mutation landscape and drug sensitivity of high- and low-expression KIF18A groups were assessed in immunotherapy cohorts and KIF18A expression cohorts. Finally, in vitro experiments were conducted to elucidate the molecular function of KIF18A in regulating the malignant behavior of PAAD.Results: KIF18A is highly expressed in PAAD and is closely related to worse clinical stage and poor prognosis. Single cell analysis revealed that KIF18A is mainly expressed in microtubules of tumor cells and participated in mitosis and cell cycle of PAAD. Further analysis revealed that the expression of KIF18A is closely related to TMB, MSI, and immune cell infiltration. In vitro experiments confirmed that KIF18A promotes the proliferation, migration and expression of adhesion molecules in PAAD, and inhibits angiogenesis. In addition, the high expression of KIF18A is positively related to ferroptosis and m6A genes expression, and its high expression is driven by mutated KRAS and TP53.Conclusion: This study confirmed that KIF18A can be used as a marker to predict the prognosis and immunotherapy of PAAD, and it participates in the formation of microtubules in PAAD cells and promotes the malignant behavior of PAAD.Keywords: pancreatic cancer, KIF18A, tumor microenvironment, prognosis, immunotherapy |
| format | Article |
| id | doaj-art-b1ddc47a05d64f40a2d2d6c1b7dc453f |
| institution | DOAJ |
| issn | 2253-1556 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | ImmunoTargets and Therapy |
| spelling | doaj-art-b1ddc47a05d64f40a2d2d6c1b7dc453f2025-08-20T02:45:43ZengDove Medical PressImmunoTargets and Therapy2253-15562025-02-01Volume 14123138100660Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic CancerNan KZhang LZou YGeng ZHuang JPeng YYin SZhang MKai Nan,1,* Lei Zhang,2,* Yujia Zou,3 Zilong Geng,3 Jing Huang,4 Yulong Peng,4 Su Yin,4 Ming Zhang5 1Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, 710054, People’s Republic of China; 2Department of Pharmacy, Shaanxi Provincial Hospital of Chinese Medicine, Xi’an, Shaanxi, 710003, People’s Republic of China; 3Department of Orthopaedics, The second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710000, People’s Republic of China; 4Department of Rehabilitative Medicine, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, People’s Republic of China; 5Department of General Practice, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, 710054, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ming Zhang, Department of General Practice, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, 710054, People’s Republic of China, Email zhangminghonghui@yeah.netPurpose: Kinesin family member 18A (KIF18A) is a member of the kinesin-8 family of motor proteins, involved in the progression and metastasis of various tumors. However, its role in pancreatic adenocarcinoma (PAAD) remains unclear.Methods: To evaluate that role, RNA sequencing datasets, complemented by pertinent clinical metadata, were procured from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) repositories. The protein expression level of KIF18A in PAAD was derived from human protein atlas (HPA) database. The differences in KIF18A expression levels and prognostic related genes were identified through multivariate Cox regression and Lasso regression analysis to construct a prognostic risk model. The Tumor Mutation Burden (TMB), Microsatellite (MSI), immune landscape, mutation landscape and drug sensitivity of high- and low-expression KIF18A groups were assessed in immunotherapy cohorts and KIF18A expression cohorts. Finally, in vitro experiments were conducted to elucidate the molecular function of KIF18A in regulating the malignant behavior of PAAD.Results: KIF18A is highly expressed in PAAD and is closely related to worse clinical stage and poor prognosis. Single cell analysis revealed that KIF18A is mainly expressed in microtubules of tumor cells and participated in mitosis and cell cycle of PAAD. Further analysis revealed that the expression of KIF18A is closely related to TMB, MSI, and immune cell infiltration. In vitro experiments confirmed that KIF18A promotes the proliferation, migration and expression of adhesion molecules in PAAD, and inhibits angiogenesis. In addition, the high expression of KIF18A is positively related to ferroptosis and m6A genes expression, and its high expression is driven by mutated KRAS and TP53.Conclusion: This study confirmed that KIF18A can be used as a marker to predict the prognosis and immunotherapy of PAAD, and it participates in the formation of microtubules in PAAD cells and promotes the malignant behavior of PAAD.Keywords: pancreatic cancer, KIF18A, tumor microenvironment, prognosis, immunotherapyhttps://www.dovepress.com/integrated-profiling-delineated-kif18a-as-a-significant-biomarker-asso-peer-reviewed-fulltext-article-ITTpancreatic cancerkif18atumor microenvironmentprognosisimmunotherapy |
| spellingShingle | Nan K Zhang L Zou Y Geng Z Huang J Peng Y Yin S Zhang M Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer ImmunoTargets and Therapy pancreatic cancer kif18a tumor microenvironment prognosis immunotherapy |
| title | Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer |
| title_full | Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer |
| title_fullStr | Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer |
| title_full_unstemmed | Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer |
| title_short | Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer |
| title_sort | integrated profiling delineated kif18a as a significant biomarker associated with both prognostic outcomes and immune response in pancreatic cancer |
| topic | pancreatic cancer kif18a tumor microenvironment prognosis immunotherapy |
| url | https://www.dovepress.com/integrated-profiling-delineated-kif18a-as-a-significant-biomarker-asso-peer-reviewed-fulltext-article-ITT |
| work_keys_str_mv | AT nank integratedprofilingdelineatedkif18aasasignificantbiomarkerassociatedwithbothprognosticoutcomesandimmuneresponseinpancreaticcancer AT zhangl integratedprofilingdelineatedkif18aasasignificantbiomarkerassociatedwithbothprognosticoutcomesandimmuneresponseinpancreaticcancer AT zouy integratedprofilingdelineatedkif18aasasignificantbiomarkerassociatedwithbothprognosticoutcomesandimmuneresponseinpancreaticcancer AT gengz integratedprofilingdelineatedkif18aasasignificantbiomarkerassociatedwithbothprognosticoutcomesandimmuneresponseinpancreaticcancer AT huangj integratedprofilingdelineatedkif18aasasignificantbiomarkerassociatedwithbothprognosticoutcomesandimmuneresponseinpancreaticcancer AT pengy integratedprofilingdelineatedkif18aasasignificantbiomarkerassociatedwithbothprognosticoutcomesandimmuneresponseinpancreaticcancer AT yins integratedprofilingdelineatedkif18aasasignificantbiomarkerassociatedwithbothprognosticoutcomesandimmuneresponseinpancreaticcancer AT zhangm integratedprofilingdelineatedkif18aasasignificantbiomarkerassociatedwithbothprognosticoutcomesandimmuneresponseinpancreaticcancer |